Pearl Bio
Build next-gen Biomaterials for Smart Biologics
- Business Model
- B2B
- Website
- pearlbio.com
- Last Round
- SeedAug 2023
- Rounds
- 1
About
Synthetic biology company using genome and ribosome engineering to produce novel biologics with diverse chemistries.
Summary
Pearl Bio is a Biotech company based in United States. Its most recent funding was a Seed round in Aug 2023. Investors include Khosla Ventures and US National Science Foundation.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Aug 2023
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company